MedPath

The Evolutionary Model of Mild-to-moderate Myopia in China

Completed
Conditions
Refractive Error
Registration Number
NCT02667509
Lead Sponsor
Sun Yat-sen University
Brief Summary

Myopia has emerged as a major health issue in east Asia, because of its increasingly high prevalence in the past few decades (now 80-90% in school-leavers), and because of the sight-threatening pathologies associated with high myopia, which now aff ects 10-20% of those completing secondary schooling in this part of the world. Similar, but less marked, changes are occurring in other parts of the world. The higher prevalence of myopia in east Asian cities seems to be associated with increasing educational pressures, combined with life-style changes, which have reduced the time children spend outside.

Detailed Description

Myopia has emerged as a major health issue in east Asia, because of its increasingly high prevalence in the past few decades (now 80-90% in school-leavers), and because of the sight-threatening pathologies associated with high myopia, which now aff ects 10-20% of those completing secondary schooling in this part of the world. Similar, but less marked, changes are occurring in other parts of the world. The higher prevalence of myopia in east Asian cities seems to be associated with increasing educational pressures, combined with life-style changes, which have reduced the time children spend outside.

In this trial, the investigators aim to study the evolutionary model of myopia in China, which could provide new insight into the social development and human adaptation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
852441
Inclusion Criteria
  • Patients complete the examination of Refractive error from 2005 to 2015 year.
Exclusion Criteria
  • Patients could not complete the examination of Refractive error

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Refractive error of both eyes measured by autorefractor and subjective measuringBaseline
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath